Birdwatch Note Rating
2024-01-15 20:42:26 UTC - NOT_HELPFUL
Rated by Participant: 85D0FCC1C92DFF9792345FD79750C0D26A6DADC60953873C8E5D8BE66268C534
Participant Details
Original Note:
Context: Vivek Ramaswamy owns a 7% stake in Roivant Sciences. Roivants financial interests in lipid nanoparticle delivery systems are publicly available in legal filings. Patent litigation involving Genevant/Roivant and Moderna are pending, they have not yet received profit https://investor.roivant.com/static-files/a7b36392-1f44-4251-87cf-8dd572f3034e https://www.fiercepharma.com/pharma/pandemic-patent-fights-continue-arbutus-genevant-coming-after-pfizer-and-biontech-new-suit
All Note Details